vs

Side-by-side financial comparison of Cytosorbents Corp (CTSO) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.

MODIV INDUSTRIAL, INC. is the larger business by last-quarter revenue ($11.1M vs $9.2M, roughly 1.2× Cytosorbents Corp). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -59.5%, a 70.5% gap on every dollar of revenue. On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -5.6%). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -3.8%).

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.

CTSO vs MDV — Head-to-Head

Bigger by revenue
MDV
MDV
1.2× larger
MDV
$11.1M
$9.2M
CTSO
Growing faster (revenue YoY)
CTSO
CTSO
+6.5% gap
CTSO
0.9%
-5.6%
MDV
Higher net margin
MDV
MDV
70.5% more per $
MDV
11.0%
-59.5%
CTSO
Faster 2-yr revenue CAGR
CTSO
CTSO
Annualised
CTSO
1.3%
-3.8%
MDV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTSO
CTSO
MDV
MDV
Revenue
$9.2M
$11.1M
Net Profit
$-5.5M
$1.2M
Gross Margin
73.7%
Operating Margin
-47.5%
45.8%
Net Margin
-59.5%
11.0%
Revenue YoY
0.9%
-5.6%
Net Profit YoY
27.4%
-22.0%
EPS (diluted)
$-0.09
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTSO
CTSO
MDV
MDV
Q4 25
$9.2M
$11.1M
Q3 25
$9.5M
$11.7M
Q2 25
$9.6M
$11.8M
Q1 25
$8.7M
$11.8M
Q4 24
$9.2M
$11.7M
Q3 24
$8.6M
$11.7M
Q2 24
$8.8M
$11.4M
Q1 24
$9.0M
$12.0M
Net Profit
CTSO
CTSO
MDV
MDV
Q4 25
$-5.5M
$1.2M
Q3 25
$-3.2M
$1.0M
Q2 25
$1.9M
$-2.0M
Q1 25
$-1.5M
$829.0K
Q4 24
$-7.6M
$1.6M
Q3 24
$-2.8M
$-587.0K
Q2 24
$-4.3M
$1.3M
Q1 24
$-6.1M
$3.7M
Gross Margin
CTSO
CTSO
MDV
MDV
Q4 25
73.7%
Q3 25
70.3%
Q2 25
70.9%
Q1 25
71.1%
Q4 24
68.4%
Q3 24
61.0%
Q2 24
73.5%
Q1 24
76.5%
Operating Margin
CTSO
CTSO
MDV
MDV
Q4 25
-47.5%
45.8%
Q3 25
-30.2%
41.4%
Q2 25
-37.6%
9.8%
Q1 25
-44.5%
40.2%
Q4 24
-37.1%
45.4%
Q3 24
-56.1%
42.0%
Q2 24
-40.4%
44.6%
Q1 24
-51.8%
55.6%
Net Margin
CTSO
CTSO
MDV
MDV
Q4 25
-59.5%
11.0%
Q3 25
-33.4%
9.0%
Q2 25
20.2%
-17.1%
Q1 25
-16.9%
7.0%
Q4 24
-82.7%
13.3%
Q3 24
-32.1%
-5.0%
Q2 24
-48.6%
11.6%
Q1 24
-67.7%
31.1%
EPS (diluted)
CTSO
CTSO
MDV
MDV
Q4 25
$-0.09
$0.02
Q3 25
$-0.05
$0.00
Q2 25
$0.03
$-0.32
Q1 25
$-0.02
$-0.01
Q4 24
$-0.14
$0.07
Q3 24
$-0.05
$-0.18
Q2 24
$-0.08
$0.03
Q1 24
$-0.11
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTSO
CTSO
MDV
MDV
Cash + ST InvestmentsLiquidity on hand
$6.2M
$14.4M
Total DebtLower is stronger
$261.5M
Stockholders' EquityBook value
$5.9M
$162.7M
Total Assets
$44.2M
$476.5M
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTSO
CTSO
MDV
MDV
Q4 25
$6.2M
$14.4M
Q3 25
$7.5M
$8.3M
Q2 25
$10.2M
$5.8M
Q1 25
$11.6M
$6.2M
Q4 24
$3.3M
$11.5M
Q3 24
$5.7M
$6.8M
Q2 24
$8.5M
$18.9M
Q1 24
$8.6M
$18.4M
Total Debt
CTSO
CTSO
MDV
MDV
Q4 25
$261.5M
Q3 25
$279.7M
Q2 25
$279.7M
Q1 25
$279.7M
Q4 24
$279.8M
Q3 24
$13.8M
$279.7M
Q2 24
$13.7M
$279.7M
Q1 24
$4.4M
$279.6M
Stockholders' Equity
CTSO
CTSO
MDV
MDV
Q4 25
$5.9M
$162.7M
Q3 25
$9.0M
$164.8M
Q2 25
$11.6M
$165.6M
Q1 25
$14.5M
$171.1M
Q4 24
$11.1M
$190.1M
Q3 24
$13.4M
$186.3M
Q2 24
$17.4M
$187.0M
Q1 24
$19.6M
$188.0M
Total Assets
CTSO
CTSO
MDV
MDV
Q4 25
$44.2M
$476.5M
Q3 25
$45.8M
$499.6M
Q2 25
$48.0M
$498.9M
Q1 25
$50.8M
$506.8M
Q4 24
$47.4M
$507.8M
Q3 24
$47.8M
$507.4M
Q2 24
$53.4M
$519.5M
Q1 24
$47.1M
$522.5M
Debt / Equity
CTSO
CTSO
MDV
MDV
Q4 25
1.61×
Q3 25
1.70×
Q2 25
1.69×
Q1 25
1.63×
Q4 24
1.47×
Q3 24
1.03×
1.50×
Q2 24
0.78×
1.50×
Q1 24
0.23×
1.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTSO
CTSO
MDV
MDV
Operating Cash FlowLast quarter
$-4.8M
$15.0M
Free Cash FlowOCF − Capex
$-4.9M
FCF MarginFCF / Revenue
-53.4%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
12.34×
TTM Free Cash FlowTrailing 4 quarters
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTSO
CTSO
MDV
MDV
Q4 25
$-4.8M
$15.0M
Q3 25
$-2.6M
$4.1M
Q2 25
$-1.5M
$3.9M
Q1 25
$-3.5M
$3.0M
Q4 24
$-2.3M
$18.2M
Q3 24
$-2.5M
$5.1M
Q2 24
$-4.8M
$4.7M
Q1 24
$-4.8M
$3.0M
Free Cash Flow
CTSO
CTSO
MDV
MDV
Q4 25
$-4.9M
Q3 25
$-2.6M
Q2 25
$-1.5M
Q1 25
$-3.5M
Q4 24
$-2.4M
Q3 24
$-2.6M
Q2 24
$-4.8M
Q1 24
$-4.9M
FCF Margin
CTSO
CTSO
MDV
MDV
Q4 25
-53.4%
Q3 25
-27.3%
Q2 25
-16.1%
Q1 25
-39.7%
Q4 24
-26.3%
Q3 24
-30.4%
Q2 24
-54.4%
Q1 24
-54.2%
Capex Intensity
CTSO
CTSO
MDV
MDV
Q4 25
1.2%
Q3 25
0.2%
Q2 25
0.4%
Q1 25
0.0%
Q4 24
0.8%
Q3 24
1.8%
Q2 24
0.2%
Q1 24
0.5%
Cash Conversion
CTSO
CTSO
MDV
MDV
Q4 25
12.34×
Q3 25
3.95×
Q2 25
-0.78×
Q1 25
3.68×
Q4 24
11.72×
Q3 24
Q2 24
3.55×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

MDV
MDV

Segment breakdown not available.

Related Comparisons